Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland
- PMID: 19625949
- DOI: 10.1097/PAI.0b013e3181ac1c20
Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland
Abstract
The aim was to compare the expression of MUC1 and carbohydrate antigens in 124 tissue samples; 42 fibroadenoma (FA), 23 nonproliferative benign diseases (NPF), 25 usual epithelial hyperplasia (UEH), 7 atypical ductal hyperplasia (ADH), and 27 breast normal tissues. An immunohistochemical approach was adopted, using the following antibodies: reactive with MUC1 variable number of tandem repeats (C595, HMFG2, and SM3 monoclonal antibodies), anti-MUC1-cytoplasmic tail polyclonal antibody (CT33), and anti-carbohydrate antigens (sialyl Lewis x, Lewis x, Lewis y, Tn, and Thomsen-Friedenreich epitopes). Positive area of reaction, intensity, and pattern of expression were considered. A reactivity index was calculated as intensity (I) x 100+percentage of positive area (A). Statistical analysis comprised frequency analysis, P < 0.05, analysis of variance, and multiple correlation with principal component analysis. All samples expressed MUC1, detected by at least one anti-MUC1 antibody whereas Lewis x was the carbohydrate antigen most frequently found in all groups whereas variable number of tandem repeats MUC1 and Lewis x showed the highest correlation: 93% of normal samples, 62.5% of NPF, 87% of FA, 85% of UEH, and finally 80% of ADH. Although principal component analysis using reactivity indexes explained only 39% of data variability, normal samples appeared grouped and separated from benign breast diseases, which remained spread. Thomsen-Friedenreich was the only antigen that showed an increased tendency for positive expression and intensity from NPF through FA, UEH to ADH, whereas it was not detected in normals. With respect to the pattern of expression, an apical pattern was predominantly found in all the groups.
Similar articles
-
Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.Int J Oncol. 2005 Nov;27(5):1289-97. Int J Oncol. 2005. PMID: 16211224
-
Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision.Pathol Oncol Res. 2007;13(2):130-8. doi: 10.1007/BF02893488. Epub 2007 Jul 3. Pathol Oncol Res. 2007. PMID: 17607374 Review.
-
Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study.Anticancer Res. 1997 Nov-Dec;17(6D):4287-92. Anticancer Res. 1997. PMID: 9494522
-
Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.Breast Cancer Res Treat. 2005 Aug;92(3):223-30. doi: 10.1007/s10549-005-2469-y. Breast Cancer Res Treat. 2005. PMID: 16155793
-
[Carbohydrate antigens as tumor marker].Nihon Geka Gakkai Zasshi. 1996 Feb;97(2):145-51. Nihon Geka Gakkai Zasshi. 1996. PMID: 8632743 Review. Japanese.
Cited by
-
Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.Biochim Biophys Acta. 2011 Apr;1815(2):224-40. doi: 10.1016/j.bbcan.2011.01.001. Epub 2011 Jan 26. Biochim Biophys Acta. 2011. PMID: 21277939 Free PMC article. Review.
-
MUCI positive cutaneous metastasis with transepidermal elimination from a breast carcinoma.Int Med Case Rep J. 2013 Nov 7;6:81-4. doi: 10.2147/IMCRJ.S52614. eCollection 2013. Int Med Case Rep J. 2013. PMID: 24235849 Free PMC article.
-
Immunohistochemical evidence of Muc1 expression during rat embryonic development.Eur J Histochem. 2010 Nov 26;54(4):e49. doi: 10.4081/ejh.2010.e49. Eur J Histochem. 2010. PMID: 21263748 Free PMC article.
-
Transmembrane mucins as novel therapeutic targets.Expert Rev Endocrinol Metab. 2011 Nov;6(6):835-848. doi: 10.1586/eem.11.70. Expert Rev Endocrinol Metab. 2011. PMID: 22201009 Free PMC article.
-
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.Tumour Biol. 2016 Oct;37(10):13769-13775. doi: 10.1007/s13277-016-5171-2. Epub 2016 Aug 1. Tumour Biol. 2016. PMID: 27481512 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous